Posted in | News | Optics and Photonics

Mitsui Chemicals’ Breakthrough Ophthalmic Lens Material Blocks UV and Shorter Wavelength Light Rays

Mitsui Chemicals, Inc. (President & CEO: Tsutomu Tannowa) announced that it commenced sales of a new breakthrough ophthalmic lens material that helps protect eyes from not only ultraviolet (10-400nm) light rays but also 400nm-420nm wavelength light.

"UV+420cut(TM)" blocks the shorter wavelength light of 400nm-420nm in addition to UV rays. (Graphic: Business Wire)

Our eyes are constantly damaged by sunlight exposure and therefore it is important to protect eyes from UV exposure. Recent studies have shown, however, that shorter wavelength light from 400nm-420nm also damages the retina, which is the most vulnerable tissue of the eye, and this can be one of the factors which accelerates the development of Age-related Macular Degeneration (AMD) and cataracts. Although many conventional sunglasses, in addition to protecting from UV rays, provide protection from shorter wavelength light, general vision correction lenses do not. Mitsui Chemicals’ newly debuted lens material, "UV+420cutTM", helps protect eyes from damaging short wavelength light.

This technology is used in the new "LUTINA®" lenses of Tokai Optical Co., Ltd.

Mitsui Chemicals provides performance-driven lens materials ranging from high to low refractive indices as well as optimum coating materials for lenses to meet diversifying global market needs. It will continue to develop groundbreaking, value-added vision care materials.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.